Download PDF
J Neurol Surg A Cent Eur Neurosurg 2013; 74(04): 262-264
DOI: 10.1055/s-0032-1304218
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Exophytic Glioblastoma Arising from the Cerebellum: Case Report and Critical Review of the Literature

Thomas Linsenmann
1   Department of Neurosurgery, University of Wuerzburg, Wuerzburg, Bavaria, Germany
,
Camelia Maria Monoranu
2   Department of Neuropathology, University of Wuerzburg, Wuerzburg, Bavaria, Germany
,
Thomas Westermaier
1   Department of Neurosurgery, University of Wuerzburg, Wuerzburg, Bavaria, Germany
,
Csanad Varallyay
3   Department of Neuroradiology, University of Wuerzburg, Wuerzburg, Bavaria, Germany
,
Ralf-Ingo Ernestus
1   Department of Neurosurgery, University of Wuerzburg, Wuerzburg, Bavaria, Germany
,
Giles Hamilton Vince
1   Department of Neurosurgery, University of Wuerzburg, Wuerzburg, Bavaria, Germany
› Author Affiliations
Further Information

Publication History

14 April 2011

07 October 2011

Publication Date:
09 July 2012 (online)

Also available at
    Permissions and Reprints

Abstract

Exophytic glioblastoma arising from the cerebellar tonsil is an extremely rare variant within the possible anatomical presentations of the glioblastoma multiforme (GBM). We report the case of a 55-year-old woman who presented with a tumor located at the cranio-cervical junction with compression of the medulla oblongata and consecutive hydrocephalus. Due to the radiological presentation, the first tentative diagnosis was a meningioma. The tumor was microsurgically removed. Histopathological examination of the tumor revealed a GBM WHO IV. The patient underwent a postoperative percutaneous radiotherapy and concomitant chemotherapy with temozolomide. GBM should be also considered in the differential diagnosis of cerebellar tumors.

Keywords

glioblastoma - cerebellar - exophytic
 

  • References

  • 1 Yamamoto M, Fukushima T, Sakamoto S , et al. Cerebellar gliomas with exophytic growth—three case reports. Neurol Med Chir (Tokyo) 1997; 37 (5) 411-415
    CrossrefPubMedGoogle Scholar
  • 2 Stupp R, Mason WP, van den Bent MJ , et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352 (10) 987-996
    CrossrefPubMedGoogle Scholar
  • 3 Henson JW. Treatment of glioblastoma multiforme: a new standard. Arch Neurol 2006; 63 (3) 337-341
    CrossrefPubMedGoogle Scholar
  • 4 DeAngelis LM. Brain tumors. N Engl J Med 2001; 344 (2) 114-123
    CrossrefPubMedGoogle Scholar
  • 5 Grahovac G, Tomac D, Lambasa S, Zoric A, Habek M. Cerebellar glioblastomas: pathophysiology, clinical presentation and management. Acta Neurochir (Wien) 2009; 151 (6) 653-657
    CrossrefPubMedGoogle Scholar
  • 6 Kuroiwa T, Numaguchi Y, Rothman MI , et al. Posterior fossa glioblastoma multiforme: MR findings. AJNR Am J Neuroradiol 1995; 16 (3) 583-589
    PubMedGoogle Scholar
  • 7 Stark AM, Nabavi A, Mehdorn HM, Blömer U. Glioblastoma multiforme-report of 267 cases treated at a single institution. Surg Neurol 2005; 63 (2) 162-169 , discussion 169
    CrossrefPubMedGoogle Scholar
  • 8 Weber DC, Miller RC, Villà S , et al. Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2006; 66 (1) 179-186
    CrossrefPubMedGoogle Scholar
  • 9 de la Fuente BP, Dalmau J, Rosenfeld M. [Glioma therapy up-date]. Neurologia 2007; 22 (3) 159-169
    PubMedGoogle Scholar
  • 10 Saito T, Hama S, Kajiwara Y , et al. Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas. Anticancer Res 2006; 26 (2B) 1351-1357
    PubMedGoogle Scholar